Hirudoid (Chondroitin Polysulfate)

Hirudoid is commonly applied to address minor vascular and bruising problems on the skin.

• Bruising (contusions) that develop after minor blunt trauma, helping to reduce discoloration.
• Superficial thrombophlebitis of small veins, aiding in the resolution of inflammation and clot formation.
• Hematoma formation following injury, supporting gradual reabsorption of pooled blood.
• Post‑procedural bruising after cosmetic or surgical interventions, assisting in faster visual improvement.
• Localized swelling associated with minor skin trauma, contributing to reduced edema.

• Chondroitin polysulfate is a sulfated glycosaminoglycan that mimics the activity of heparin when applied to the skin. It binds to antithrombin III and enhances its inhibition of thrombin and factor Xa, leading to localized anticoagulant effects. The compound also interferes with platelet aggregation and promotes fibrinolysis, which together help to disperse small clots and reduce edema in superficial tissues and improve microcirculation.

Topical application of Hirudoid may be associated with skin‑related adverse reactions, most of which are mild and reversible.

Common

• Mild erythema or redness at the application site, usually resolving within a few hours.
• Transient itching or pruritus that does not require medical treatment.
• Slight burning sensation during or shortly after application, disappearing without intervention.
• Minor skin dryness or peeling that improves with moisturization.

Serious

• Allergic contact dermatitis with swelling, vesicles, and intense itching, requiring discontinuation.
• Severe skin ulceration or necrosis at the treated area, indicating tissue damage.
• Systemic hypersensitivity such as urticaria or angio‑edema, potentially needing emergency care.
• Unexpected increase in bruising or hematoma expansion despite therapy.

Before using Hirudoid, several precautionary measures should be considered to minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin.
• Do not use on large surface areas or under occlusive dressings unless directed.
• Discontinue use if signs of allergic reaction appear.
• Consult a healthcare professional before use during pregnancy, lactation, or in children.
• Keep out of reach of children and store at room temperature away from direct sunlight.
• Do not combine with other topical anticoagulants without medical advice.

Hirudoid may interact with other agents applied to the skin or systemic anticoagulants.

Avoid

• Concurrent use of other topical heparinoids or strong anticoagulant creams.
• Application over areas treated with chemical peels or laser therapy.

Use with caution

• Systemic anticoagulant or antiplatelet medications (e.g., warfarin, aspirin) – monitor for increased bleeding.
• Topical corticosteroids – may alter skin absorption.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied locally – potential additive bruising risk.
• Herbal or dietary supplements with anticoagulant properties (e.g., ginkgo, garlic) – consider overall bleeding tendency.
• Photodynamic therapy or intense UV exposure – may increase skin sensitivity when combined.